利用反义RNA技术分析春化相关基因VER17在冬小麦花发育过程中的功能

为了研究小麦春化相关基因VER17的功能,应用反义RNA技术,将VER17基因的反义片段构建到载体pBI121上,通过花粉管通道法获取转基因小麦.对T0代转基因植株GUS染色以及PCR等分子鉴定,得到14株含反义VERJ7基因片段的阳性转基因植株.对T0代和T1代的表型观察结果显示,VER17反义转基因植株开花时间延迟,并且穗的顶部和基部小花出现明显的退化.表明春化相关基因VER17在小麦发育过程中可能起到促进植物开花以及穗顶端和基部花发育的作用,减少小花退化,同时对雄蕊的发育也有影响.     

研究生生物化学课程教学改革的尝试

针对化工和轻化工专业研究生生物化学的教学特点,从教学方法、教学内容和教学手段上进行了一些改革和尝试。     

黄土丘陵区沙打旺草地土壤水分过耗与恢复

研究了黄土丘陵区沙打旺 (Astragalusadsurgens)草地土壤水分的动态规律和恢复过程及人为调控土壤水分的效果。结果表明 :沙打旺在该区生长年限为 6～ 7a,生物量形成的高峰期在第 3～ 4年 ,之后土壤水分大量亏缺 ,生物量逐年下降 ,第 6年生物量和水分均下降到最低点。同时土壤水分的消耗深度与根系的分布相一致 ,土壤干层主要集中在根系分布的密集区 0 .3～0 .8m。随着沙打旺生长年限的延长及根系的下扎 ,土壤干层逐渐加深 ,3～ 6年生沙打旺草地土壤干层平均厚度为 2 .3m;土壤水分要自然恢复到种植前的含水量需要 6～ 7a;通过水平阶和水平沟整地进行人工调控 ,土壤水分比自然恢复可提前 2～ 3a,一般需要 4～ 5 a的时间即可恢复正常     

佛坪自然保护区野生大熊猫交配行为的观察

On March 26 and 27, 2003, we observed six and five giant pandas assembled together respectively in Huodiba and Lijiagou districts of Sanguanmiao, Foping Nature Reserve, Shaanxi Province, China. The mating sites were located in the coniferous forest and mixed coniferous and deciduous forest, with steep slope and sparse shrubs and bamboos. Wind power was estimated over 3rd category in those two days. The competition and lighting among male pandas were observed, and the mating right with the female panda was mainly based on the hierarchical ordering. However, not all the winners during competition can be access to mating with the female panda. For wild giant panda, its mating system is maybe plastic, which perhaps is affected by environment, time and panda population itself. Cubs or sub-adults are observed oceurring at the mating site, which is considered to be linked with the learning of the reproductive behavior. Our results maybe provide a useful guideline to the management and breeding of giant pandas in the captivity.     

呼吸道合胞病毒Long株的培养及应用

建立可稳定收获高滴度RSVLong株病毒的培养方法 ,所获得的RSVLong株病毒液用于RSV抗体ELISA检测。RSVLong株病毒 33℃传至 4代后 ,病毒滴度升高 ,出现典型的细胞病变。以RSVLong株病毒液作抗原所建立的ELISA试剂盒能检测出RSV特异性抗体。     

High IFN－α expression is associated with the induction of experimental autoimmune uveitis （EAU） in Fischer 344 rat

INTRODUCTIONThe CD4 T cells can be subdivided intoTh1 and Th2 subsets based on their secreted cy-tokine profile. Th1 cells characteristical1y secreteInterferonry (IFN--ry), whereas Th2 cells maiuly pro--duce IL--4[1]. IL-12 po1arizes the differentiation ofnaitre, CD4 T cells towards Th1 pathWay, in con-trast IL--4 directs T cell differentiation towards Th2pathWay The broken balance between Th1 and Th2immune responses and predominant Th1 responseare crucial factors in initiation…     

智力低下患者的手纹分析

本文对安徽合肥和芜湖地区284例（男145人,女139人）2－59岁智力低下患者的手纹进行了分析。结果表明：患者的皮纹参数与正常对照组有明显的统计学差异,其中尺箕、箕／箕组合、帐弓、皮纹密度、atd角、t距比、掌褶通贯型、悉尼型、过渡Ⅰ型和小指短小类型等项参数均高于对照组（P＜0.01);而简斗、斗／斗组合、a-dRC、t-dRC低于对照组（P＜0.01),a-bRC亦低于对照组（P＜0.05)。这些皮纹参数可以作为智力低下患者的辅助诊断指标。     

Cloning and characterization of a mouse liver-specific gene mfrep-1, upregulated in liver regeneration

Human fibrinogen-related protein-1/liver fibrinogen-related protein-1 (HFREP-1/LFIRE-1), a liver-specificprotein, is a member of fibrinogen superfamily that exerts various biological activities. However, the func-tion of HFREP-1/LFIRE-1 in liver remains unknown. Here we isolated its mouse ortholog gene-mousefibrinogen-related protein-1 (mfrep-1), which encoded 314 amino acids, exhibiting 80.4% similarity toHFREP-1/LFIRE-1. Northern blot analysis revealed that 1.2-kb mfrep-1 mRNA was detected selectivelyin mouse liver. To explore the function of MFREP-1, we examined the levels of mfrep-1 mRNA duringregeneration after 70% partial hepatectomy (PHx) in mice. mfrep-1 mRNA increased in the regeneratingliver and reached the first shoulder peak at 2-4 h after PHx. Cycloheximide pretreatment could suppress theinduction of mfrep-1, indicating the up-regulation of this gene need de novo protein synthesis. Its mRNAcontinued to elevate at 6 h thereafter and reached the second peak at 24 h. The enhanced expression ofmfrep-1 maintained high until 72 h and then declined slowly to the basal level. Immunohistochemistryassessment confirmed the up-regulated expression of MFREP-1 protein in parenchymal cells during liverregeneration. These data suggested that MFREP-1 might play an important role in liver regeneration andbe involved in the regulation of cell growth.     

Restoration of CD3+CD56+ cell level improves skin lesions in severe psoriasis: A pilot clinical study of adoptive immunotherapy for patients with psoriasis using autologous cytokine-induced killer cells

Psoriasis is a chronic inflammatory skin disorder mediated by the cells and molecules of both the innate and adaptive immune systems. Autologous cytokine-induced killer (CIK) cell infusion is considered an effective and safe cancer treatment and is licensed for this use in China. Accumulated evidence indicating that CD3⁺CD56⁺ cells are significantly decreased in psoriatic patients prompted us to investigate if the restoration of CD3⁺CD56⁺ cells may be beneficial for psoriatic patients. We designed a clinical trial for psoriasis treatment that involved CIK cell infusion because CIK cells include a large amount of CD3⁺CD56⁺ T cells (NCT01894373 at www.clinicaltrials.gov). Six patients with severe psoriasis were initially enrolled, and four of them exhibited markedly lower levels of CD3⁺CD56⁺ cells in their peripheral blood (PB) relative to healthy donors. CIK cell infusion-associated toxicity was not observed in any infusion. The percentage of CD3⁺CD56⁺ cells in the PB markedly increased and the psoriasis area and severity index (PASI) synchronously decreased in four patients with lower CD3⁺CD56⁺ cell contents, and two of them obtained a more than 4-month PASI75 after completing a four-cycle treatment. However, a decrease in the CD3⁺CD56⁺ cells was observed concomitantly with disease recurrence after short-term amelioration. In contrast, no obvious improvement was observed in the two patients with nearly normal CD3⁺CD56⁺ cells in the PB before treatment. These observations suggest that the normalization of the CD3⁺CD56⁺ cell level may improve the skin lesions of severe psoriasis and warrant further clinical trials for severe psoriasis using repeated CIK adoptive immunotherapy.